Delivery Order SPE2DB20D1109-SPE2DB24FP15J
- Not listed
- This federal contract award is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,718.08 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 26, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price of $2,488.52 and an Ultimate Completion Date of May 2, 2024. It is not set aside for any specific business type. Amerisourcebergen...
- This federal contract award is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,730.00 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 10, 2024. This award is not associated with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a ceiling value of $1,064.70 and a completion date of February 24, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $1,092.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a completion date of March 26, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with any set-aside requirements, indicating...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML pharmaceutical products. The $1,952.94 contract has a completion date of February 5, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and is not operating under a set-aside designation. This award is issued under a larger indefinite delivery contract (IDC)...
- This federal contract award, valued at $1,055.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a completion date of March 8, 2024. The contract is a delivery order type, with a firm fixed price pricing structure. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is...
- This federal contract award, valued at $1,055.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with an ultimate completion date of November 15, 2024. The contract utilizes a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML pharmaceutical products. The contract has a potential value of $1,055.52 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is one of multiple delivery orders issued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,355.91 firm fixed-price delivery order is for the supply of 225 mg/1.5 ml AJOVY auto-injector products. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FP15JDelivery Order
This federal contract award is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,571.88, with a completion date of May 13, 2024. There is no set-aside designation for this contract. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 5/10/24 |